Boettcher Investigator Research Summaries 2016

Boettcher Investigator Research Summaries 2016

The following individuals were selected as Boettcher Investigators for 2016. For detailed profiles of their research, click on their names.

Colorado State University 

  • Rushika Perera, Ph.D., Assistant Professor of RNA Virology – Exploiting vulnerabilities in mosquito metabolism for prevention of human arboviral transmission
  • Timothy J. Stasevich, Ph.D., Assistant Professor of Biochemistry and Molecular Biology – Imaging cancer epigenetics in living cells

 

National Jewish Health 

  • James L. Crooks, Ph.D., Assistant Professor of Biostatistics and BioinformaticsWildfire smoke and pediatric asthma

 

University of Colorado Anschutz Medical Campus 

  • Wen-Yuan Elena Hsieh, M.D., Assistant Professor of Immunology & Microbiology and Assistant Professor of Pediatrics, Division of Allergy and Immunology – Immune dysregulation in pediatric SLE pathogenesis
  • Ethan G. Hughes, Ph.D., Assistant Professor of Cell and Developmental Biology – Intrinsic and extrinsic mechanisms regulating cortical remyelination
  • Bernard L. Jones, Ph.D., Assistant Professor of Medical Physics – Achieving safe and effective dose escalation in pancreatic SBRT through tumor tracking and robust treatment planning
  • Cristin Welle, Ph.D., Assistant Professor of Neurosurgery and Bioengineering – Development of high-density neural sensors for bioelectronics therapeutics
  • Hongjin Zheng, Ph.D., Assistant Professor of Biochemistry and Molecular Genetics – Mechanical studies of disease-related substrates entering mitochondria via protein import machinery TOM-TIM

 

University of Colorado Boulder 

  • Sabrina Spencer, Ph.D., Assistant Professor of Chemistry and Biochemistry – Elucidating the causes and consequences of slow-cycling cells within isogenic population

 

University of Denver

  • Schuyler van Engelenburg, Ph.D., Assistant Professor of Natural Sciences and Mathematics, Department of Biological Sciences – Site-specific targeting of engineered retroviruses to the Interleukin 2 Receptor locus for correction of genetic immunodeficiency
No Comments

Sorry, the comment form is closed at this time.